PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.

Jones SM, Mann A, Conrad K, Saum K, Hall DE, McKinney LM, Robbins N, Thompson J, Peairs AD, Camerer E, Rayner KJ, Tranter M, Mackman N, Owens AP 3rd

Open source

DOI
10.1161/atvbaha.117.310082
Published
2018 Jun
Container
Arteriosclerosis, thrombosis, and vascular biology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/atvbaha.117.310082,
  title = {PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.},
  author = {Jones SM and Mann A and Conrad K and Saum K and Hall DE and McKinney LM and Robbins N and Thompson J and Peairs AD and Camerer E and Rayner KJ and Tranter M and Mackman N and Owens AP 3rd},
  year = {2018},
  journal = {Arteriosclerosis, thrombosis, and vascular biology},
  doi = {10.1161/atvbaha.117.310082},
  url = {https://doi.org/10.1161/atvbaha.117.310082}
}

RIS

TY  - JOUR
TI  - PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.
AU  - Jones SM
AU  - Mann A
AU  - Conrad K
AU  - Saum K
AU  - Hall DE
AU  - McKinney LM
AU  - Robbins N
AU  - Thompson J
AU  - Peairs AD
AU  - Camerer E
AU  - Rayner KJ
AU  - Tranter M
AU  - Mackman N
AU  - Owens AP 3rd
PY  - 2018
JO  - Arteriosclerosis, thrombosis, and vascular biology
DO  - 10.1161/atvbaha.117.310082
UR  - https://doi.org/10.1161/atvbaha.117.310082
ER  - 

APA

SM, J., A, M., K, C., K, S., DE, H., LM, M., N, R., J, T., AD, P., E, C., KJ, R., M, T., N, M., & 3rd, O. A. (2018). PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.. Arteriosclerosis, thrombosis, and vascular biology. https://doi.org/10.1161/atvbaha.117.310082

Source records